Stratasys Releases Second Quarter 2024 Financial Results

MINNEAPOLIS & REHOVOT, Israel--(BUSINESS WIRE)--Stratasys Ltd. (Nasdaq: SSYS) ("Stratasys" or the "Company"), a leader in polymer 3D printing solutions, today announced financial results for the second quarter 2024.

Second Quarter 2024 Financial Results Compared to Second Quarter 2023:

• Revenue of $138.0 million, compared to $159.8 million ($154.6 million net of divestments).
• GAAP gross margin of 43.8%, compared to 41.5%.
• Non-GAAP gross margin of 49.0%, compared to 48.5%.
• GAAP operating loss of $26.0 million, compared to an operating loss of $33.7 million.
• Non-GAAP operating loss of $3.2 million, compared to non-GAAP operating income of $5.0 million.
• GAAP net loss of $25.7 million, or $0.36 per diluted share, compared to a net loss of $38.6 million, or $0.56 per diluted share.
• Non-GAAP net loss of $3.0 million, or $0.04 per diluted share, compared to non-GAAP net income of $2.5 million, or $0.04 per diluted share.
• Adjusted EBITDA of $2.3 million, compared to $10.6 million.
• Cash used in operating activities of $2.4 million, compared to $23.2 million.

Business Update:

Following a comprehensive strategic review, Stratasys is taking focused restructuring actions to further strengthen its industry leading balance sheet and robust business model to more effectively weather all market cycles. The initiatives are expected to support ongoing focused innovation investments and facilitate wider adoption of additive manufacturing.

Effective immediately, the Company will streamline operations and enhance its go to market strategy to focus on the highest growth potential products, materials and software solutions. By the end of this year, the Company will have rightsized its workforce by approximately 15%. These steps are expected to produce approximately $40 million in annual cost savings beginning in the first quarter of 2025, along with annualized EBITDA margins of 8% at current revenue levels. Furthermore, in addition to sustainable profitability, the Company will remain well-positioned to act upon opportunities that may arise.

Dr. Yoav Zeif, Stratasys' Chief Executive Officer, stated, "For the Company to maintain its industry leadership, we continuously evaluate and assess our business model to ensure we are optimally aligned with evolving market conditions. We are confident that our efforts will enable our customers to more effectively address their biggest manufacturing challenges, which should lead to increased adoption of our additive technologies. This realignment is critical to ensure that we can achieve our objectives to deliver sustained profitability and cash flow, while remaining ready to capture opportunities when the spending cycle improves, positioning Stratasys to deliver outsized shareholder value."

Dr. Zeif continued, "During the quarter we achieved strong consumables sales, and strengthened our market position with the addition of leading products, including the H350 version 1.5 printer, the J5 Digital Anatomy printer, and many exciting new software offerings. We understand the importance of a disciplined approach to balancing investment in innovation with staying focused on delivering the most impactful additive manufacturing applications to our customers and value to shareholders."

2024 Financial Outlook:

Based on current market conditions and assuming that the impacts of global inflationary pressures, relatively high interest rates and supply chain costs do not impede economic activity further, the Company is updating its outlook for the full year 2024 as follows:

• Revenue of $570 million to $580 million.
  • Third quarter revenue slightly higher than second quarter revenue.
• Non-GAAP gross margin of 48.7% to 49.0%.
• Operating expenses of $276 million to $278 million.
• Non-GAAP operating margin of 0.5% to 1.0%.
• GAAP net loss of $106 million to $91 million, or ($1.50) to ($1.29) per diluted share.
  • Includes one-time extraordinary costs associated with Stratasys' strategic alternatives process.
• Non-GAAP net income of $1 million to $4 million, or $0.01 to $0.05 per diluted share.
• Adjusted EBITDA of $24 million to $27 million.
• Capital expenditures of $20 million to $25 million.

Non-GAAP earnings guidance excludes $30 million to $32 million of share-based compensation expense, $25 million to $27 million of projected amortization of intangible assets, and reorganization and other expenses of $39 million to $45 million. Non-GAAP guidance includes tax adjustments of $2 million to $3 million on the above non-GAAP items.

Appropriate reconciliations between GAAP and non-GAAP financial measures are provided in a table at the end of our press release and slide presentation, with itemized detail concerning the non-GAAP financial measures.

Stratasys Ltd. Second Quarter 2024 Webcast and Conference Call Details

The Company plans to webcast its conference call to discuss its second quarter 2024 financial results on Thursday, August 29, 2024, at 8:30 a.m. (ET).

The investor conference call will be available via live webcast on the Stratasys website at investors.stratasys.com, or directly at the following web address:

https://event.choruscall.com/mediaframe/webcast.html?webcastid=2xc8Kb5W

To participate by telephone, the U.S. toll-free number is 877-407-0619 and the international dial-in is [phone]. Investors are advised to dial into the call at least ten minutes prior to the call to register. The webcast will be available for six months at investors.stratasys.com, or by accessing the above-provided web address.

Stratasys is leading the global shift to additive manufacturing with innovative 3D printing solutions for industries such as aerospace, automotive, consumer products, healthcare, fashion and education. Through smart and connected 3D printers, polymer materials, a software ecosystem, and parts on demand, Stratasys solutions deliver competitive advantages at every stage in the product value chain. The world's leading organizations turn to Stratasys to transform product design, bring agility to manufacturing and supply chains, and improve patient care.

To learn more about Stratasys, visit www.stratasys.com, the Stratasys blog, X.com (formerly Twitter), LinkedIn, or Facebook. Stratasys reserves the right to utilize any of the foregoing social media platforms, including the Company's websites, to share material, non-public information pursuant to the SEC's Regulation FD. To the extent necessary and mandated by applicable law, Stratasys will also include such information in its public disclosure filings.

Stratasys is a registered trademark and the Stratasys signet is a trademark of Stratasys Ltd. and/or its subsidiaries or affiliates. All other trademarks are the property of their respective owners.

Cautionary Statement Regarding Forward-Looking Statements

The statements in this press release regarding Stratasys' strategy, and the statements regarding its projected future financial performance, including the financial guidance concerning its expected results for 2024 and beyond, are forward-looking statements reflecting management's current expectations and beliefs. These forward-looking statements are based on current information that is, by its nature, subject to rapid and even abrupt change. Due to risks and uncertainties associated with Stratasys' business, actual results could differ materially from those projected or implied by these forward-looking statements. These risks and uncertainties include, but are not limited to: the degree of our success at introducing new or improved products and solutions that gain market share; the degree of growth of the 3D printing market generally; the impact of potential shifts in the prices or margins of the products that we sell or services that we provide, including due to a shift towards lower margin products or services; the impact of competition and new technologies; potential further charges against earnings that we could be required to take due to impairment of additional goodwill or other intangible assets; the extent of our success at successfully consummating and integrating into our existing business acquisitions or investments in new businesses, technologies, products or services; the global macro-economic environment, including headwinds caused by relatively high interest rates, unfavorable currency exchange rates and other growth-inhibiting conditions; potential changes in our management and board of directors; global market, political and economic conditions, and in the countries in which we operate in particular; costs and potential liability relating to litigation and regulatory proceedings; risks related to infringement of our intellectual property rights by others or infringement of others' intellectual property rights by us; the extent of our success at maintaining our liquidity and financing our operations and capital needs; the impact of tax regulations on our results of operations and financial condition; and those additional factors referred to in Item 3.D "Key Information - Risk Factors", Item 4, "Information on the Company", Item 5, "Operating and Financial Review and Prospects," and all other parts of our Annual Report on Form 20-F for the year ended December 31, 2023, which we filed with the U.S. Securities and Exchange Commission, or SEC, on March 11, 2024 (the "2023 Annual Report"). Readers are urged to carefully review and consider the various disclosures made throughout our 2023 Annual Report and the Report of Foreign Private Issuer on Form 6-K that attaches Stratasys' unaudited, condensed consolidated financial statements and its review of its results of operations and financial condition, for the quarterly and six-month periods ended June 30, 2024, which will be furnished to the SEC on or about August 29, 2024, and our other reports filed with or furnished to the SEC, which are designed to advise interested parties of the risks and factors that may affect our business, financial condition, results of operations and prospects. Any guidance provided, and other forward-looking statements made, in this press release are provided or made (as applicable) as of the date hereof, and Stratasys undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Use of Non-GAAP Financial Measures

The non-GAAP data included herein, which excludes certain items as described below, are non-GAAP financial measures. Our management believes that these non-GAAP financial measures are useful information for investors and shareholders of our company in gauging our results of operations (i) on an ongoing basis after excluding mergers, acquisitions, divestments and strategic process-related expense or gains and reorganization-related charges or gains, and legal provisions and (ii) excluding non-cash items such as share-based compensation expenses, acquired intangible assets amortization, including intangible assets amortization related to equity-method investments, impairment of long-lived assets and goodwill, revaluation of our investments and the corresponding tax effect of those items. These non-GAAP adjustments either do not reflect actual cash outlays that impact our liquidity and our financial condition or have a non-recurring impact on the statement of operations, as assessed by management. These non-GAAP financial measures are presented to permit investors to more fully understand how management assesses our performance for internal planning and forecasting purposes. The limitations of using these non-GAAP financial measures as performance measures are that they provide a view of our results of operations without including all items indicated above during a period, which may not provide a view of our performance that is comparable to those of other companies in our industry. Investors and other readers should consider non-GAAP measures only as supplements to, not as substitutes for or as superior measures to, the measures of financial performance prepared in accordance with GAAP. Reconciliation between results on a GAAP and non-GAAP basis is provided in a table below.

Stratasys Ltd.
Consolidated Balance Sheets
(in thousands, except share data)
		June 30,				December 31,
		2024				2023
ASSETS
Current assets
Cash and cash equivalents		$	70,858			$	82,585
Short-term bank deposits			80,000				80,000
Accounts receivable, net of allowance for credit losses of $1,424 and $1,449 as of June 30, 2024 and December 31, 2023, respectively			150,483				172,009
Inventories			196,505				192,976
Prepaid expenses			8,570				7,929
Other current assets			17,575				24,596
Total current assets			523,991				560,095
Non-current assets
Property, plant and equipment, net			187,189				197,552
Goodwill			99,174				100,051
Other intangible assets, net			116,461				127,781
Operating lease right-of-use assets			17,928				18,895
Long-term investments			121,755				115,083
Other non-current assets			15,409				14,448
Total non-current assets			557,916				573,810
Total assets		$	1,081,907			$	1,133,905
LIABILITIES AND EQUITY
Current liabilities
Accounts payable		$	49,495			$	46,785
Accrued expenses and other current liabilities			31,627				36,656
Accrued compensation and related benefits			26,666				33,877
Deferred revenues - short-term			50,914				52,610
Operating lease liabilities - short-term			5,966				6,498
Total current liabilities			164,668				176,426
Non-current liabilities
Deferred revenues - long-term			18,880				23,655
Deferred income taxes			558				723
Operating lease liabilities - long-term			11,780				12,162
Contingent consideration			11,851				11,900
Other non-current liabilities			23,699				24,200
Total non-current liabilities			66,768				72,640
Total liabilities			231,436				249,066
Equity
Ordinary shares, NIS 0.01 nominal value, authorized 180,000 thousands
shares; 71,132 shares and 69,656 shares issued			199				195
and outstanding at June 30, 2024 and December 31, 2023, respectively			3,111,057				3,091,649
Additional paid-in capital
Accumulated other comprehensive loss			(9,133	)			(7,079	)
Accumulated deficit			(2,251,652	)			(2,199,926	)
Total Equity			850,471				884,839
Total liabilities and equity		$	1,081,907			$	1,133,905

Stratasys Ltd.
Consolidated Statements of Operations
(in thousands, except per share data)
		Three Months Ended June 30,								Six Months Ended June 30,
			2024				2023				2024				2023
		unaudited				unaudited				unaudited				unaudited
Revenues
Products		$	93,594			$	109,112			$	192,790			$	210,083
Services			44,447				50,639				89,301				99,045
			138,041				159,751				282,091				309,128
Cost of revenues
Products			46,756				57,576				96,513				108,689
Services			30,785				35,953				61,181				68,822
			77,541				93,529				157,694				177,511
Gross profit			60,500				66,222				124,397				131,617
Operating expenses
Research and development, net			25,680				24,305				49,657				45,780
Selling, general and administrative			60,863				75,576				125,236				136,293
			86,543				99,881				174,893				182,073
Operating loss			(26,043	)			(33,659	)			(50,496	)			(50,456	)
Financial income (expense), net			(726	)			687				491				1,460
Loss before income taxes			(26,769	)			(32,972	)			(50,005	)			(48,996	)
Income tax expense			(762	)			725				(1,478	)			4,500
Share in profits (losses) of associated companies			1,788				(4,918	)			(243	)			(7,343	)
Net loss		$	(25,743	)		$	(38,615	)		$	(51,726	)		$	(60,839	)
Net loss per share
Basic		$	(0.36	)		$	(0.56	)		$	(0.74	)		$	(0.89	)
Diluted		$	(0.36	)		$	(0.56	)		$	(0.74	)		$	(0.89	)
Weighted average ordinary shares outstanding
Basic			70,746				68,648				70,367				68,107
Diluted			70,746				68,648				70,367				68,107

		Three Months Ended June 30,
		2024				Non-GAAP				2024				2023				Non-GAAP			2023
		GAAP				Adjustments				Non-GAAP				GAAP				Adjustments			Non-GAAP
		U.S. dollars and shares in thousands (except per share amounts)
	Gross profit (1)	$	60,500			$	7,175			$	67,675			$	66,222			$	11,283		$	77,505
	Operating income (1,2)		(26,043	)			22,845				(3,198	)			(33,659	)			38,666			5,007
	Net income (loss) (1,2,3)		(25,743	)			22,774				(2,969	)			(38,615	)			41,148			2,533
	Net income (loss) per diluted share (4)	$	(0.36	)		$	0.32			$	(0.04	)		$	(0.56	)		$	0.60		$	0.04
(1)	Acquired intangible assets amortization expense						4,489												5,014
	Non-cash stock-based compensation expense						1,010												999
	Restructuring and other related costs						1,676												3,378
	Impairment charges and write off						-												1,892
							7,175												11,283
(2)	Acquired intangible assets amortization expense						1,111												2,686
	Non-cash stock-based compensation expense						6,335												7,024
	Restructuring and other related costs						3,639												2,468
	Contingent consideration						523												347
	Legal and other expenses						4,062												14,858
							15,670												27,383
							22,845												38,666
(3)	Corresponding tax effect						204												213
	Equity method related expenses						(1,593	)											2,094
	Finance expenses						1,318												175
						$	22,774											$	41,148
(4)	Weighted average number of ordinary shares outstanding - Diluted		70,746								70,746				68,648							69,272

		Six Months Ended June 30,
		2024				Non-GAAP				2024				2023				Non-GAAP			2023
		GAAP				Adjustments				Non-GAAP				GAAP				Adjustments			Non-GAAP
		U.S. dollars and shares in thousands (except per share amounts)
	Gross profit (1)	$	124,397			$	13,314			$	137,711			$	131,617			$	16,582		$	148,199
	Operating income (1,2)		(50,496	)			46,099				(4,397	)			(50,456	)			56,981			6,525
	Net income (loss) (1,2,3)		(51,726	)			47,073				(4,653	)			(60,839	)			64,454			3,615
	Net income (loss) per diluted share (4)	$	(0.74	)		$	0.67			$	(0.07	)		$	(0.89	)		$	0.95		$	0.05
(1)	Acquired intangible assets amortization expense						9,573												9,015
	Non-cash stock-based compensation expense						1,962												1,931
	Restructuring and other related costs						1,779												3,744
	Impairment charges and write off						-												1,892
							13,314												16,582
							-
(2)	Acquired intangible assets amortization expense						3,570												4,880
	Non-cash stock-based compensation expense						14,032												14,332
	Restructuring and other related costs						4,559												4,266
	Revaluation of investments						1,900												580
	Contingent consideration						1,034												612
	Legal and other expenses						7,690												15,729
							32,785												40,399
							46,099												56,981
							0
(3)	Corresponding tax effect						438												3,251
	Equity method related expenses						(629	)											3,584
	Finance expenses						1,165												638
						$	47,073											$	64,454
(4)	Weighted average number of ordinary shares outstanding - Diluted		70,367								70,367				68,107							68,683

Stratasys Ltd.
Reconciliation of GAAP to Non-GAAP Forward Looking Guidance
Fiscal Year 2024
(in millions, except per share data)
GAAP net loss	($106) to ($91)
Adjustments
Stock-based compensation expense	$30 to $32
Intangible assets amortization expense	$25 to $27
Reorganization and other	$39 to $45
Tax expense (benefit) related to Non-GAAP adjustments	$2 to $3
Non-GAAP net income	$1 to $4
GAAP loss per share	($1.50) to ($1.29)
Non-GAAP diluted earnings per share	$0.01 to $0.05

Contacts

Yonah Lloyd
CCO & VP Investor Relations
[e-mail]